GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eupraxia Pharmaceuticals Inc (TSX:EPRX) » Definitions » Cash Payments for Loans

Eupraxia Pharmaceuticals (TSX:EPRX) Cash Payments for Loans


View and export this data going back to 2021. Start your Free Trial

What is Eupraxia Pharmaceuticals Cash Payments for Loans?

Cash Payments for Loans only applicable to companies reporting Cash Flow from Operations in direct method.


Eupraxia Pharmaceuticals Business Description

Traded in Other Exchanges
Address
201-2067 Cadboro Bay Road, Victoria, BC, CAN, V8R 5G4
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.
Executives
Michael Wilmink Director
Amanda Michelle Malone Senior Officer
Paul Anthony Brennan Senior Officer
James Allen Helliwell Director
James Besser Director or Senior Officer of 10% Security Holder
Morgan Frank Director or Senior Officer of 10% Security Holder
Llc Manchester Management Company 10% Security Holder
John Montalbano Director